ARDS - Aridis Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
4,876
19,986
8,232
20,897
Total Cash
4,876
19,986
8,232
20,897
Net Receivables
1,000
-
-
0
Other Current Assets
-
6,810
6,885
7,070
Total Current Assets
11,626
26,796
15,117
27,967
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
4,190
2,942
2,413
1,829
Accumulated Depreciation
-2,043
-1,585
-1,155
-823
Net property, plant and equipment
2,147
1,357
1,258
1,006
Equity and other investments
-
-
-
9
Intangible Assets
17
22
27
32
Other long-term assets
827
931
987
557
Total non-current assets
3,069
0
0
0
Total Assets
14,695
26,796
15,117
27,967
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
4,300
696
439
-
Accounts Payable
2,308
5,240
1,886
1,755
Accrued liabilities
9,564
6,464
1,330
2,974
Deferred revenues
20,173
20,838
18,748
14,602
Other Current Liabilities
15
110
37
-
Total Current Liabilities
36,898
33,348
22,440
19,331
Non-current liabilities
Long Term Debt
-
5,282
276
-
Deferred revenues
737
913
854
5,000
Other long-term liabilities
-
363
228
-
Total non-current liabilities
2,029
6,558
1,358
5,000
Total Liabilities
38,927
40,906
23,798
24,331
Stockholders' Equity
Common Stock
3
2
1
1
Retained Earnings
-195,666
-165,295
-123,102
-100,769
Accumulated other comprehensive income
5,051
-
-
-
Total stockholders' equity
-24,232
-14,110
-8,681
3,636
Total liabilities and stockholders' equity
14,695
26,796
15,117
27,967